Swiss National Bank’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.38M | Buy |
132,694
+2,000
| +2% | +$28K | ﹤0.01% | 1855 |
|
|
2026
Q1 | $1.23M | Hold |
130,694
| – | – | ﹤0.01% | 2074 |
|
|
2025
Q4 | $1.62M | Buy |
130,694
+2,700
| +2% | +$35.9K | ﹤0.01% | 1966 |
|
|
2025
Q3 | $1.83M | Sell |
127,994
-4,700
| -4% | -$64.4K | ﹤0.01% | 1896 |
|
|
2025
Q2 | $1.63M | Sell |
132,694
-1,900
| -1% | -$27.6K | ﹤0.01% | 1911 |
|
|
2025
Q1 | $2.96M | Buy |
134,594
+4,900
| +4% | +$115K | ﹤0.01% | 1552 |
|
|
2024
Q4 | $2.94M | Sell |
129,694
-1,400
| -1% | -$30.6K | ﹤0.01% | 1633 |
|
|
2024
Q3 | $2.38M | Hold |
131,094
| – | – | ﹤0.01% | 1764 |
|
|
2024
Q2 | $3.82M | Hold |
131,094
| – | – | ﹤0.01% | 1432 |
|
|
2024
Q1 | $4.65M | Sell |
131,094
-13,300
| -9% | -$532K | ﹤0.01% | 1345 |
|
|
2023
Q4 | $6.29M | Sell |
144,394
-17,600
| -11% | -$693K | ﹤0.01% | 1140 |
|
|
2023
Q3 | $6.19M | Buy |
161,994
+1,500
| +0.9% | +$63.1K | ﹤0.01% | 1147 |
|
|
2023
Q2 | $6.6M | Sell |
160,494
-1,700
| -1% | -$81.8K | ﹤0.01% | 1140 |
|
|
2023
Q1 | $9.31M | Sell |
162,194
-19,300
| -11% | -$1.09M | 0.01% | 909 |
|
|
2022
Q4 | $10.2M | Buy |
181,494
+4,100
| +2% | +$209K | 0.01% | 904 |
|
|
2022
Q3 | $7.51M | Buy |
177,394
+900
| +0.5% | +$46.1K | 0.01% | 1041 |
|
|
2022
Q2 | $9.54M | Buy |
176,494
+6,300
| +4% | +$378K | 0.01% | 944 |
|
|
2022
Q1 | $10.9M | Buy |
170,194
+11,800
| +7% | +$777K | 0.01% | 974 |
|
|
2021
Q4 | $10.6M | Sell |
158,394
-400
| -0.3% | -$27.1K | 0.01% | 981 |
|
|
2021
Q3 | $10.9M | Buy |
158,794
+700
| +0.4% | +$49.5K | 0.01% | 960 |
|
|
2021
Q2 | $10.8M | Sell |
158,094
-5,500
| -3% | -$389K | 0.01% | 976 |
|
|
2021
Q1 | $11.3M | Buy |
163,594
+1,600
| +1% | +$108K | 0.01% | 938 |
|
|
2020
Q4 | $10.5M | Sell |
161,994
-1,500
| -0.9% | -$80.7K | 0.01% | 910 |
|
|
2020
Q3 | $7.72M | Buy |
163,494
+3,300
| +2% | +$157K | 0.01% | 933 |
|
|
2020
Q2 | $7.53M | Buy |
160,194
+18,600
| +13% | +$914K | 0.01% | 921 |
|
|
2020
Q1 | $6.33M | Buy |
141,594
+2,300
| +2% | +$121K | 0.01% | 814 |
|
|
2019
Q4 | $8.12M | Buy |
139,294
+2,600
| +2% | +$155K | 0.01% | 869 |
|
|
2019
Q3 | $8.21M | Buy |
136,694
+1,900
| +1% | +$113K | 0.01% | 840 |
|
|
2019
Q2 | $7.53M | Buy |
134,794
+2,800
| +2% | +$144K | 0.01% | 891 |
|
|
2019
Q1 | $7.36M | Buy |
131,994
+4,000
| +3% | +$204K | 0.01% | 872 |
|
|
2018
Q4 | $5.77M | Sell |
127,994
-2,300
| -2% | -$126K | 0.01% | 901 |
|
|
2018
Q3 | $8.58M | Buy |
130,294
+14,200
| +12% | +$882K | 0.01% | 800 |
|
|
2018
Q2 | $7.48M | Buy |
116,094
+7,300
| +7% | +$452K | 0.01% | 851 |
|
|
2018
Q1 | $6.02M | Buy |
108,794
+2,400
| +2% | +$126K | 0.01% | 942 |
|
|
2017
Q4 | $5.09M | Buy |
106,394
+6,400
| +6% | +$313K | 0.01% | 1045 |
|
|
2017
Q3 | $5.05M | Hold |
99,994
| – | – | 0.01% | 1008 |
|
|
2017
Q2 | $5.45M | Buy |
99,994
+1,700
| +2% | +$81.2K | 0.01% | 942 |
|
|
2017
Q1 | $4.14M | Hold |
98,294
| – | – | 0.01% | 1091 |
|
|
2016
Q4 | $4.22M | Buy |
98,294
+2,000
| +2% | +$81.3K | 0.01% | 1064 |
|
|
2016
Q3 | $3.98M | Sell |
96,294
-800
| -0.8% | -$33.5K | 0.01% | 1054 |
|
|
2016
Q2 | $3.87M | Hold |
97,094
| – | – | 0.01% | 1052 |
|
|
2016
Q1 | $3.16M | Buy |
97,094
+20,400
| +27% | +$635K | 0.01% | 1138 |
|
|
2015
Q4 | $2.6M | Hold |
76,694
| – | – | 0.01% | 1159 |
|
|
2015
Q3 | $2.28M | Buy |
76,694
+7,214
| +10% | +$226K | 0.01% | 1209 |
|
|
2015
Q2 | $1.91M | Buy |
69,480
+1,223
| +2% | +$32.6K | 0.01% | 1331 |
|
|
2015
Q1 | $1.72M | Buy |
68,257
+979
| +1% | +$23.1K | ﹤0.01% | 1395 |
|
|
2014
Q4 | $1.49M | Buy |
67,278
+1,713
| +3% | +$34.7K | 0.01% | 1483 |
|
|
2014
Q3 | $1.33M | Hold |
65,565
| – | – | 0.01% | 1484 |
|
|
2014
Q2 | $1.26M | Hold |
65,565
| – | – | ﹤0.01% | 1575 |
|
|
2014
Q1 | $1.23M | Buy |
65,565
+14,923
| +29% | +$288K | ﹤0.01% | 1563 |
|
|
2013
Q4 | $988K | Buy |
50,642
+6,850
| +16% | +$126K | ﹤0.01% | 1511 |
|
|
2013
Q3 | $720K | Sell |
43,792
-3,914
| -8% | -$62.8K | ﹤0.01% | 1682 |
|
|
2013
Q2 | $714K | Buy |
+47,706
| New | +$699K | ﹤0.01% | 1667 |
|
Other funds holding IART
RCMNY
PCMI
Swiss National Bank's IART Position: Q2 2026 in Review
Swiss National Bank increased its Integra LifeSciences (IART) stake by 1.5% in Q2 2026, buying an estimated $28K and bringing the position to 132,694 shares worth $2.38M. The position accounts for ﹤0.01% of the portfolio, ranked #1855.
Swiss National Bank first reported a position in IART in Q2 2013 and has held it in 53 quarters since. The position peaked at $11.3M in Q1 2021. 212 funds tracked by Wall St. Rank hold IART as of Q2 2026.
- Swiss National Bank held 132,694 shares of Integra LifeSciences worth $2.38M as of Q2 2026.
- Swiss National Bank bought 2,000 Integra LifeSciences shares in Q2 2026, an estimated $28K.
- Integra LifeSciences made up ﹤0.01% of Swiss National Bank's portfolio in Q2 2026, its #1855 holding.
- Swiss National Bank first reported a position in Integra LifeSciences in Q2 2013 and has held it in 53 quarters since.
- Swiss National Bank's Integra LifeSciences position peaked at $11.3M in Q1 2021.
- 212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.
Based on Swiss National Bank's 13F filing for Q2 2026, filed 11 Aug 2026.